Amorphous polyphosphate–hydroxyapatite: A morphogenetically active substrate for bone-related SaOS-2 cells in vitro

werner e g muller,emad tolba,heinz c schroder,rafael munozespi,barbel diehlseifert,xiaohong wang
DOI: https://doi.org/10.1016/j.actbio.2015.11.060
IF: 10.633
2016-01-01
Acta Biomaterialia
Abstract:There is increasing evidence that inorganic calcium-polyphosphates (polyP) are involved in human bone hydroxyapatite (HA) formation. Here we investigated the morphology of the particles, containing calcium phosphate (CaP) with different concentrations of various Na–polyP concentrations, as well as their effects in cell culture. We used both SaOS-2 cells and human mesenchymal stem cells. The polymeric phosphate readily binds calcium ions under formation of insoluble precipitates. We found that addition of low concentrations of polyP (<10wt.%, referred to the CaP deposits) results in an increased size of the HA crystals. Surprisingly, at higher polyP concentrations (>10wt.%) the formation of crystalline HA is prevented and amorphous polyP/HA hybrid particles with a size of ≈50nm are formed, most likely consisting of polyP molecules linked via Ca2+ bridges to the surface of the CaP deposits. Further studies revealed that the polyP–CaP particles cause a strong upregulation of the expression of the genes encoding for two marker proteins of bone formation, collagen type I and alkaline phosphatase. Based on their morphogenetic activity the amorphous polyP–CaP particles offer a promising material for the development of bone implants, formed from physiological inorganic precursors/polymers.
What problem does this paper attempt to address?